Teva Pharmaceuticals USA Inc. is recalling approximately 13,699 bottles of Matzim LA (diltiazem hydrochloride) Extended-Release Tablets in 180 mg and 240 mg strengths. The recall was initiated because the tablets failed dissolution tests, meaning they dissolved at a rate below the required specification limits. No incidents or injuries have been reported in connection with this issue. These prescription medications are sold in 30-count bottles and were distributed nationwide across the United States and Puerto Rico.
Failed dissolution can result in the medication not releasing into the body at the intended rate, which may reduce the drug's effectiveness in treating heart-related conditions and high blood pressure. This could lead to a loss of blood pressure control or other cardiovascular concerns.
You have 2 options:
Manufactured by Actavis Laboratories FL, Inc.
Manufactured by Actavis Laboratories FL, Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.